CollaborationQuantro Therapeutics cashes in milestone payment from Boehringer IngelheimLatest NewsViennese biotech QUANTRO Therapeutics identifies small molecule targeting an onkogenic transcription factor in Boehringer Ingelheim collab. Read more 5 June 2024 https://european-biotechnology.com/wp-content/uploads/2024/06/quantro.png 922 1366 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-06-05 09:12:232024-07-07 09:29:23Quantro Therapeutics cashes in milestone payment from Boehringer Ingelheim